NO874989L - Fremgangsmaate for fremstilling av tabletter eller kapsler som inneholder et super-desintegrasjonsmiddel. - Google Patents

Fremgangsmaate for fremstilling av tabletter eller kapsler som inneholder et super-desintegrasjonsmiddel.

Info

Publication number
NO874989L
NO874989L NO87874989A NO874989A NO874989L NO 874989 L NO874989 L NO 874989L NO 87874989 A NO87874989 A NO 87874989A NO 874989 A NO874989 A NO 874989A NO 874989 L NO874989 L NO 874989L
Authority
NO
Norway
Prior art keywords
desint
migrant
tablets
super
procedure
Prior art date
Application number
NO87874989A
Other languages
English (en)
Other versions
NO175884B (no
NO175884C (no
NO874989D0 (no
Inventor
Coenraad F Lerk
Gerad Klaas Bolhuis
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO874989D0 publication Critical patent/NO874989D0/no
Publication of NO874989L publication Critical patent/NO874989L/no
Publication of NO175884B publication Critical patent/NO175884B/no
Publication of NO175884C publication Critical patent/NO175884C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO874989A 1986-04-01 1987-11-30 Fremgangsmåte for fremstilling av en presset tablett som inneholder methylprednisolon og et super-desintegrasjonsmiddel NO175884C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84662086A 1986-04-01 1986-04-01
PCT/US1987/000302 WO1987005804A1 (en) 1986-04-01 1987-02-17 Methylprednisolone/sodium carboxymethyl starch tablet composition

Publications (4)

Publication Number Publication Date
NO874989D0 NO874989D0 (no) 1987-11-30
NO874989L true NO874989L (no) 1987-11-30
NO175884B NO175884B (no) 1994-09-19
NO175884C NO175884C (no) 1994-12-28

Family

ID=25298443

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874989A NO175884C (no) 1986-04-01 1987-11-30 Fremgangsmåte for fremstilling av en presset tablett som inneholder methylprednisolon og et super-desintegrasjonsmiddel

Country Status (8)

Country Link
EP (1) EP0301006B1 (no)
JP (1) JPH01501934A (no)
KR (1) KR880701098A (no)
AU (1) AU7084587A (no)
DK (1) DK167341B1 (no)
HK (1) HK58497A (no)
NO (1) NO175884C (no)
WO (1) WO1987005804A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
ES2160582T3 (es) * 1992-04-03 2001-11-16 Nippon Kayaku Kk Capsula dura de ocfosfato de citarabina.
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
GB2292079B (en) * 1994-08-12 1998-07-15 Flexpharm Ltd Coated prednisolone preparation for the treatment of inflamatory bowel disease
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
UA72207C2 (uk) 1998-04-07 2005-02-15 Брістол- Майєрс Сквібб Фарма Компані Фармацевтична композиція ефавіренцу з добавкою дезінтегруючих агентів у вигляді швидкорозчинних капсул або таблеток та спосіб її виготовлення
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
DE19855203A1 (de) * 1998-11-30 2000-05-31 Kurt Heinz Bauer Coprozessiertes Polysaccharidprodukt
DE19922537A1 (de) * 1999-05-10 2000-11-16 Roland Bodmeier Darreichungsform zur Applikation in Körperöffnungen
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
HU230253B1 (hu) 2001-01-26 2015-11-30 Merck Sharp & Dohme Corp Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
WO2005013964A1 (ja) * 2003-08-08 2005-02-17 Ajinomoto Co., Inc. ナテグリニド含有製剤
JP2007533697A (ja) * 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
CA2617051C (en) * 2005-07-29 2013-12-17 Stichting Groningen Centre For Drug Research Ph-controlled pulsatile delivery system, methods for preparation and use thereof
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
JP6037687B2 (ja) * 2011-07-08 2016-12-07 サノフィ株式会社 グリメピリドを含有する口腔内崩壊錠
BE1021446B1 (nl) * 2015-01-06 2015-11-24 Stasisport Pharma Nv Methylprednisolon tablet en werkwijze
CN106265568B (zh) * 2016-08-30 2018-08-10 林州中农颖泰生物肽有限公司 一种水溶性醋酸地塞米松片及其制备方法
CN109925288A (zh) * 2017-12-18 2019-06-25 江苏开元药业有限公司 一种糖皮质激素药物片剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
EP0052076B1 (de) * 1980-11-12 1985-05-29 Ciba-Geigy Ag Schnellzerfallende Arzneimittel-Presslinge
GB8403360D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions

Also Published As

Publication number Publication date
WO1987005804A1 (en) 1987-10-08
JPH01501934A (ja) 1989-07-06
NO175884B (no) 1994-09-19
HK58497A (en) 1997-05-09
NO175884C (no) 1994-12-28
KR880701098A (ko) 1988-07-25
NO874989D0 (no) 1987-11-30
EP0301006A1 (en) 1989-02-01
DK624287A (da) 1987-11-27
DK624287D0 (da) 1987-11-27
AU7084587A (en) 1987-10-20
DK167341B1 (da) 1993-10-18
EP0301006B1 (en) 1992-05-06

Similar Documents

Publication Publication Date Title
NO874989D0 (no) Fremgangsmaate for fremstilling av tabletter eller kapsler som inneholder et super-desintegrasjonsmiddel.
NO175286C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat som omfatter dobbeltveggede mikrokapsler
DE3784594D1 (de) Mikrokapseln enthaltende pharmazeutische zusammensetzungen.
NO870579L (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
NO883054D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat inneholdende somatostatinanaloger.
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
NO872174L (no) Fremgangsmaate for fremstilling av polypeptidpreparater med oekt biologisk tilgjengelighet.
NO870866D0 (no) Fremgangsmaate for fremstilling av et terapeutisk kombinasjonspreparat.
NO870177D0 (no) Fremgangsmaate for fremstilling av et soetemiddel.
NO874355L (no) Fremgangsmaate for fremstilling av glycolipid som inneholder n-glycolylneuraminsyre.
NO872158D0 (no) Fremgangsmaate ved fremstilling av nye aromatiske naftylderivater.
NO873514D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
NO153951C (no) Fremgangsmaate for fremstilling av en farmasoeytisk tilberedning som inneholder 8-metoksy-furo-(3[ ,2[:6,7)-cumarin.
NO873339D0 (no) Fremgangsmaate til fremstilling av hydrogenperoksyd.
FI864474L (fi) Skruvkapsyloeppnare.
NO873400D0 (no) Fremgangsmaate for fremstilling av sulfidfri alkalivaeske.
NO872094D0 (no) Fremgangsmaate ved fremstilling av dbh-inhiberende forbindelser.
ES2016824B3 (es) Poliuretanos preparados a partir de polioles que contienen cristales liquidos y proceso para la preparacion de los mismos.
NO880345L (no) Fremgangsmaate for fremstilling av alkyl-tert-butyletere.
NO872690D0 (no) Fremgangsmaate for fremstilling av mercaptoacylprolin.
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
ES2023670B3 (es) Procedimiento de preparacion de una mezcla que contiene ciclohexanol y ciclohexanona a partir de ciclohexano.
NO874617D0 (no) Fremgangsmaate til fremstilling av 2,6-diamino-3-halogenobenzylpyridiner.
IT8319993A0 (it) Composizioni farmaceutiche contenenti composti a scheletro flavanonico, procedimento per lapreparazione di detti composti e nuovi composti ottenuti.